Felipe Couñago, National Clinical Director of GenesisCare, Spain, shared a post on LinkedIn about a paper he co-authored with colleagues published in the World Journal of Clinical Oncology:
“Just came across this excellent review in the World Journal of Clinical Oncology:
‘Radiotherapy treatment time delay evidence, part I: Update on cervical, anal, prostate, and head and neck cancers.’
A comprehensive and timely synthesis on how treatment delays can impact outcomes across several tumor types, a powerful reminder that time truly matters in radiotherapy.
Congratulations to the authors for this outstanding contribution to the field and for highlighting such a critical aspect of clinical practice.”
Title: Radiotherapy treatment time delay evidence, part I: Update on cervical, anal, prostate, and head and neck cancers
Authors: Jose Antonio González Ferreira, Castalia Fernandez, Daniela Gonsalves, Imanol Paguey, Felipe Couñago
You can read the Full Article in World Journal of Clinical Oncology.
More posts featuring Felipe Couñago.
